Sometimes, the best medicine isn’t medicine alone – don't you agree? As part of our Humanizing Health Awards program, our colleagues around Teva have the opportunity to support local non-profit initiatives that make a difference to patients' and caregivers' life, beyond traditional healthcare. Recently, our Teva Mexico team and their families visited the Ronald McDonald Children's Foundation, one of our 2023 Humanizing Awards winners, and enjoyed a heartwarming day with the children supported by the Foundation. The Ronald McDonald Children's Foundation supports thousands of children undergoing cancer treatments each year. They provide crucial services such as housing, food, and sustenance during their stay, along with psychological support for parents, allowing the families to focus on their child's recovery. Our employees and their families engaged in games, meaningful conversations, and even a lively piñata session, bringing smiles and joy to all! Moments like these keep us motivated and show that we are all in for better health — making a positive impact in our communities. #HumanizingHealth #WeAreAllInForBetterHealth #CommunityImpact #Unidosparaunamejorsalud #HumanizandoLaSalud #Tevapharm
O nás
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/
- Web
-
http://www.tevapharm.com
Externí odkaz pro organizaci Teva Pharmaceuticals
- Obor
- Farmaceutická výroba
- Velikost společnosti
- 10 000 a více zaměstnanců
- Ústředí
- Tel-Aviv
- Typ
- Veřejná společnost
- Speciality
- generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine a oncology
Lokality
Zaměstnanci společnosti Teva Pharmaceuticals
Aktualizace
-
Hoje celebramos o Dia do Oncologista homenageando esses profissionais dedicados que enfrentam diariamente a batalha contra o câncer com coragem, conhecimento e empatia. Nosso compromisso com a saúde vai além da fabricação de medicamentos, reconhecemos e valorizamos o trabalho incansável destes profissionais que estão na linha de frente na luta pela saúde e qualidade de vida de milhares de pacientes. Vamos continuar a construir juntos um futuro onde o câncer seja cada vez mais tratável e a qualidade de vida dos pacientes esteja sempre em primeiro lugar. 💪💚 #DiaDoOncologista #Oncologia #Saúde #TevaBrasil #Inovação #QualidadeDeVida #CuidadoCompaixão
-
-
“Bravery is not about conquering our fears, but about not letting our fears stop us.” After surgery for a benign brain tumor, Susanne White was sure she’d “snap back” to her old self. Instead, she found herself navigating a new normal that took – and still takes – a lot of getting used to. Drawing on her years of experience as a family caregiver, Susanne followed 4 golden rules that would help her adapt to her “new normal” in a gentle, healthy manner. Today, she shares these 4 steps for family caregivers or anyone struggling to navigate new changes in their lives: https://ow.ly/7Xtn50Sp1hQ #CaregiverSupport #OvercomingChallenges #Caregivers #LifeEffects #Tevapharm
-
-
Biologics – complex medicines made by living cells – can have significant therapeutic benefits over chemically produced small molecule drugs in treating severe illnesses. Learn more about biologic medicines and their importance in the fight against cancer and other diseases: https://ow.ly/IJom50SwsQl #InnovativeMedicine #Biologics #Tevapharm
-
-
💡 Innovation. 🌱 Growth. 🏳️🌈 Diversity. These are the cornerstones of Teva's commitment to shaping the future of healthcare. Meet Victoria Li and Mareike Maubach, Teva graduates who are embodying these values in their roles. 👩🔬 Vikki, with her passion for impact-driven work, is making waves in R&D at our West Chester hub. From project management to collaborating on groundbreaking biologics launches, she's proving adaptability and curiosity are key ingredients for success. 📊 Meanwhile, Mareike, a powerhouse in analytical thinking, started as a quality analyst and is now applying her innovative thinking in our EU commercial team. Embracing challenges, she’s unlocking her full potential with every step. Learn more about Vikki and Mareike's journeys in our latest article >> https://ow.ly/NWoA50SsnFi #TevaTalent #FutureLeaders #InnovationJourney #HealthcareInnovation #Tevapharm
-
-
"Depression can affect how we think, and it can make it difficult for us to appreciate who we are. Realizing that I'm not a "permanently depressed person" has put some control back into my hands." Living with depression for over 13 years, Amy Marlow shares her 7 coping strategies for when she feels an oncoming depressive episode. Read her full article here: https://ow.ly/7Jtt50SoWW3 #MentalWellness #CopingStrategies #Depression #LifeEffects #Tevapharm
-
-
We’re thrilled to be named on TIME’s inaugural World’s Most Sustainable Companies of 2024. This reflects Teva’s commitment to a Healthy Future, with sustainability central to our business as we provide medicines to millions of patients around the world each day. Thank you, TIME and Statista, for this recognition. About this year’s World’s Most Sustainable Companies: https://ow.ly/cE7z50SsIqM About Teva's sustainability strategy: https://ow.ly/9FK250SsIq5 #Sustainability #HealthyFuture #Tevapharm
-
☀️ Planning a vacation with chronic migraine? With the right strategies, you can enjoy your trip and lessen the chance of a severe attack. Today, Ciara O’Rourke shares her 5 top tips for planning a vacation when living with chronic migraine. Read her 5 tips here: https://ow.ly/cM2m50Sp26O Bring on summer and bon voyage! #MigraineVacation #MigraineTips #MigraineAwareness #LifeEffects #Tevapharm
-
-
Dr. Beryl Ojwang loved going to her father’s lab as a kid to play scientist. 🧪🔬 Her curiosity fueled her interest in patient care and led her on an educational road full of twists and turns that resulted in a deep foundational knowledge of patients and the complex healthcare systems they navigate. Today, as an Associate Medical Director at Teva, Beryl uses her experience and technology to effectively connect with patients and physicians. Learn more about Beryl and how AI helps bring patient and physician insights to Teva scientists: https://ow.ly/IGKI50SqPEz #HealthcareInnovation #RandD #Innovation #Tevapharm
-
-
How is Pride celebrated around the globe? 🌎 🏳️🌈 From colorful parades to a sense of belonging, Teva people from Mexico to Israel, the US, and the UK share their unique stories and Pride experiences… Because love is love no matter where in the world you are 💛 Take a look at our latest article to read their stories >> https://ow.ly/q92q50SmoZV Join us in celebrating our incredible LGBTQIA+ colleagues and our continued efforts to create an inclusive environment for ALL our employees. Rodrigo Fernandez Makarand Bagul, MBBS MBA Kevin Galownia Idan Simchony 🏳️🌈🇮🇱🎗️ #TevaPride #Inclusion #Diversity #PrideMonth2024 #Equality #Tevapharm
Přidružené stránky
Podobné stránky
Akcie
TEVA
NYSE
20 minut zpoždění
17,28 US$
- Otvírací cena
- 17,13
- Denní minimum
- 17,065
- Denní maximum
- 17,395
Data od Refinitiv
Financování
Teva Pharmaceuticals
Celkem 3 kola
![]()
Royalty Pharma
Zobrazit více informací na crunchbase
Poslední kolo
Kapitál post IPO
Externí odkaz na Crunchbase pro poslední kolo financování
100 000 000,00 US$
Investoři